Published online before print January 28, 2008, doi: 10.1161/CIRCULATIONAHA.107.711275
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:940-951.)
© 2008 American Heart Association, Inc.
Molecular Cardiology |
Signal Transducer and Activator of Transcription-1 Is Critical for Apoptosis in Macrophages Subjected to Endoplasmic Reticulum Stress In Vitro and in Advanced Atherosclerotic Lesions In Vivo
From the Departments of Medicine (W.L., J.M.T., T.A.S., I.T.), Pathology and Cell Biology (I.T.), and Physiology and Cellular Biophysics (I.T.), Columbia University, New York, NY; Monash Institute of Medical Research (A.S.), Monash University, Victoria, Australia; and CVPath Institute Inc (F.D.K., R.V.), Gaithersburg, Md.
Correspondence to Ira Tabas, MD, PhD, Department of Medicine, Columbia University, 630 W 168th St, New York, NY 10032. E-mail iat1{at}columbia.edu
Received April 25, 2007; accepted November 15, 2007.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— Macrophage apoptosis is a critical process in the formation of necrotic cores in vulnerable atherosclerotic plaques. In vitro and in vivo data suggest that macrophage apoptosis in advanced atheromata may be triggered by a combination of endoplasmic reticulum stress and engagement of the type A scavenger receptor, which together induce death through a rise in cytosolic calcium and activation of toll-like receptor-4.
Methods and Results— Using both primary peritoneal macrophages and studies in advanced atheromata in vivo, we introduce signal transducer and activator of transcription-1 (STAT1) as a critical and necessary component of endoplasmic reticulum stress/type A scavenger receptor–induced macrophage apoptosis. We show that STAT1 is serine phosphorylated in macrophages subjected to type A scavenger receptor ligands and endoplasmic reticulum stress in a manner requiring cytosolic calcium, calcium/calmodulin-dependent protein kinase II, and toll-like receptor-4. Remarkably, apoptosis was inhibited by 
80% to 90% (P<0.05) by STAT1 deficiency or calcium/calmodulin-dependent protein kinase II inhibition. In vivo, nuclear Ser-P-STAT1 was found in macrophage-rich regions of advanced murine and human atheromata. Most important, macrophage apoptosis was decreased by 61% (P=0.034) and plaque necrosis by 34% (P=0.02) in the plaques of fat-fed low density lipoprotein receptor null Ldlr–/– mice transplanted with Stat1–/– bone marrow.
Conclusions— STAT1 is critical for endoplasmic reticulum stress/type A scavenger receptor–induced apoptosis in primary tissue macrophages and in macrophage apoptosis in advanced atheromata. These findings suggest a potentially important role for STAT1-mediated macrophage apoptosis in atherosclerotic plaque progression.
Key Words: apoptosis • atherosclerosis • cholesterol • macrophage • plaque
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
In advanced atherosclerosis, death of macrophages in the setting of defective phagocytic clearance of apoptotic cells contributes to the development of plaque necrosis.1,2 Plaque necrosis, in turn, is thought to promote plaque disruption and arterial thrombosis, which are the proximate causes of acute cardiovascular events.1–3 Our laboratory established an important principle of advanced lesional macrophage death, namely involvement of the endoplasmic reticulum (ER) stress pathway known as the unfolded protein response (UPR).4,5 Some laboratories have discovered important evidence that the UPR is activated in intimal cells, including macrophages, in advanced murine and human plaques.6–9 In particular, Myoishi et al9 recently showed a dramatic rise in UPR markers, including the transcription factor CHOP (GADD153), and intimal cell apoptosis in autopsy specimens from humans with vulnerable and ruptured plaques but not stable lesions and in atherectomy specimens from humans with unstable angina but not stable angina. Although the UPR is primarily an ER repair pathway, a branch of the UPR involving the effector CHOP can trigger apoptosis when the cell senses that repair is no longer possible.4,10 In terms of causation, we have shown that advanced lesional macrophage death and plaque necrosis are decreased in atherosclerotic apolipoprotein E–deficient (Apoe–/–) mice in the setting of ER stress prevention5 or CHOP deficiency (Edward Thorp, PhD; Gang Li, PhD; George Kuriakose, MSc; David Ron, MD; and I.T., unpublished data, 2007).
Clinical Perspective p 951
Our work on the UPR began with a model of advanced lesional macrophage death that is present in advanced plaques, namely intracellular accumulation of lipoprotein-derived free cholesterol (FC).11 FC enrichment of macrophages, like many ER stressors, activates the UPR through depletion of ER luminal calcium.12,13 Since then, mechanistic studies have led to a broader concept of advanced lesional macrophage death beyond the FC model. These studies have shown that any combination of inducers of ER stress and ligands for the macrophage type A scavenger receptor (SRA), both of which are expressed prominently in advanced lesions, triggers macrophage apoptosis.14,15 Macrophage SRA recognizes a number of lesional molecules and atherogenic lipoproteins, including those used to enrich macrophages with cholesterol in the FC model.16 The SRA also is a pattern recognition receptor of the innate immune system, and endotoxin-free SRA ligands activate other pattern recognition receptors, notably toll-like receptor-4 (TLR4).15,17,18 In this context, our studies have shown that SRA ligands trigger 2 critical proapoptotic events in ER-stressed macrophages: TLR4-mediated activation of a proapoptotic MyD88 pathway15 and SRA-mediated suppression of a prosurvival TLR4-TRIF-interferon (IFN)-β pathway.14,15
In this report, we show that apoptosis of ER-stressed macrophages also requires signal transducer and activator of transcription-1 (STAT1) and calcium/calmodulin-dependent protein kinase II (CaMKII) in a process involving cytosolic calcium and TLR4. Most important, we provide evidence that activated STAT1 is present in atheromata and that lesional macrophage apoptosis is suppressed in the setting of STAT1 deficiency.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
See the online-only Data Supplement for expanded Methods.
Assay of Macrophage Apoptosis
Midstage and late-stage apoptosis in peritoneal macrophages was assayed by annexin V and propidium iodine staining, respectively, with the Vybrant Apoptosis Assay Kit No. 2 (Molecular Probes, Carlsbad, Calif). At the end of incubation, the macrophages were gently washed once with PBS and incubated for 15 minutes at room temperature with 120 µL annexin-binding buffer (25 mmol/L HEPES, 140 mmol/L NaCl, 1 mmol/L EDTA, pH 7.4, 0.1% BSA) containing 10 µL Alexa Fluor 488–conjugated annexin V and 1 µL of 100-µg/mL propidium iodine. The staining mixture was then removed and replaced with 120 µL annexin-binding buffer. The cells were viewed immediately at room temperature with an Olympus IX-70 inverted fluorescent microscope equipped with filters appropriate for fluorescein and rhodamine, and images were obtained with a Cool Snap charge-coupled device camera (RS Photometrics, Tucson, Ariz) equipped with imaging software from Roper Scientific (Trenton, NJ). Three fields of cells (650 cells per field) were photographed for each condition, and the number of annexin V/propidium iodine–positive cells in each field was counted and expressed as a percent of the total number of cells.
Bone Marrow Transplantation
Ten-week-old female low-density lipoprotein receptor null Ldlr–/– mice were lethally irradiated with 10 Gy from a cesium 
source 4 to 6 hours before transplantation. Bone marrow cells were collected from the femurs and tibias of donor Stat1–/– or Stat1+/+ mice by flushing with sterile medium (RPMI 1640, 2% FBS, 10 U/mL heparin, 50 U/mL penicillin, 50 µg/mL streptomycin). The bone marrow cells were washed extensively and resuspended in RPMI medium containing 20 mmol/L HEPES, 50 U/mL penicillin, and 50 µg/mL streptomycin. Each recipient mouse was injected with 5x106 bone marrow cells through the tail vein. The mice were given acidified water containing 100 mg neomycin and 10 mg polymyxin B sulfate 1 week before and 2 weeks after transplantation. Six weeks after transplantation, the mice were fed a "Western-type" diet (21% anhydrous milk fat and 0.15% cholesterol, TD88137, Harlan-Teklad) for 10 or 12 weeks.
Atherosclerotic Lesion Analysis
On the day of the analysis, food was removed from the cages in the morning, and the mice were fasted for 8 hours. The animals were then anesthetized with isoflurane, and blood was withdrawn by cardiac puncture. The heart was then perfused with PBS, and the heart and proximal aorta were harvested. The heart and aorta were perfused ex vivo with PBS and then transferred to 10% buffered formalin, processed, and embedded in paraffin. Starting from the atrial leaflets, serial sections (6 µm thick) were prepared so that every eighth section was stained with Harris hematoxylin and eosin. Atherosclerotic lesions in 6 sections were analyzed in a blinded fashion with a Nikon Labophot-2 microscope (Nikon Instruments Inc, Melville, NY) equipped with a Sony CCD-Iris/RGB color videocamera (Sony Electronics Inc, San Diego, Calif) attached to a computerized imaging system using IMAGE-PRO PLUS 3.0 software (Media Cybernetics, Bethesda, Md). Aortic lesion area was quantified by averaging the lesion areas of the 6 sections. Necrotic areas were defined as those regions of the lesions that lacked nuclei and cytoplasm.
In Situ TdT-Mediated dUTP Nick-End Labeling Assays
Apoptotic cells in the intima of atherosclerotic lesions were detected by the TdT-mediated dUTP nick-end labeling (TUNEL) technique using the TMR red in situ cell death detection kit (Roche Diagnostics, Indianapolis, Ind) and the stringent method of Kockx.19 Sections of proximal aorta were deparaffinized, rehydrated, and treated with 2 µg/mL proteinase K (Roche) for 30 minutes at 37°C in a humidified chamber. The treated sections were incubated in TdT reaction mixture containing TMR red dUTP for 1 hour at 37°C in a humidified chamber. After washing, genomic DNA was stained with DAPI for 5 minutes at room temperature; the slides then were mounted with coverslips. TUNEL staining was analyzed with an Olympus IX-70 inverted fluorescent microscope equipped with a Cool Snap charge-coupled device camera and imaging software (Roper Scientific). Fluorescent images were captured and analyzed with image Photoshop analysis software (Adobe Systems, San Jose, Calif).
Statistical Analysis
Data are presented as mean±SEM. Absent error bars in the bar graphs signify SEM values smaller than the graphic symbols. The significance of paired data was determined by Student t test. Data with >2 groups or 
2 independent variables were analyzed with ANOVA, followed by the Bonferroni post hoc test. Significance is indicated by an asterisk in the figures with an explanation in the figure legends; nonsignificance is indicated by NS in the figures.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
SRA-Induced Apoptosis in ER-Stressed Macrophages Requires STAT1 and Is Preceded by Serine Phosphorylation of STAT1
During the course of another study investigating an ER stress response mediator called interferon-inducible, double-stranded RNA-regulated elF-2
protein kinase (PKR), we conceived the hypothesis that STAT1, the activity of which is modulated by PKR,20 may play a role in ER stress–induced macrophage apoptosis. To test this idea, we compared SRA/ER stress–induced apoptosis in peritoneal macrophages from wild-type (WT) versus Stat1–/– mice. Confirming our previous work, both intracellular FC enrichment with an SRA-interacting lipoprotein and treatment with the SRA ligand fucoidan plus the UPR activator thapsigargin triggered apoptosis, as indicated by an increase in annexin V staining (Figure 1A and 1B, WT). In contrast, Stat1–/– macrophages were markedly protected from apoptosis by both inducers (80% to 90% inhibition of apoptosis; P<0.05), indicating an essential role of STAT1 in this model of macrophage apoptosis (Figure 1A and 1B, Stat1–/–). The decrease in apoptosis in Stat1–/– macrophages could not be explained by a decrease in either SRA (not shown) or CHOP induction (Figure 1C).
|
STAT1 is activated by phosphorylation of Y701 or S727.21 Y701 phosphorylation is essential for STAT1 dimerization, nuclear translocation, and DNA binding.21 S727 phosphorylation enhances the transcriptional activity of tyrosine-phosphorylated STAT1 or, in some cases, has been reported to participate in signaling in the absence of Y701 phosphorylation.21–23 As shown in Figure 2A, FC loading of macrophages induced serine, whereas tyrosine phosphorylation was not detected, and total STAT1 was not increased. In contrast, very little serine phosphorylation was seen in nonloaded or cholesteryl ester–loaded macrophages, which show no or very little evidence of ER stress.4 As expected, IFN induced highly detectable levels of tyrosine phosphorylation and serine phosphorylation of STAT1.21 Previous work has suggested that nuclear Ser-P-STAT1 can occur through serine phosphorylation of a constitutive pool of nuclear STAT1.23 We detected STAT1 in nuclear fractions isolated from untreated macrophages, and Ser-P-STAT1 was increased with FC loading. Although total nuclear STAT1 was modestly increased after FC loading, this increase was much less than that seen with IFN, which is known to induce STAT1 nuclear translocation21 (Figure 2B). These data suggest that at least a portion of FC-induced Ser-P-STAT1 occurs through phosphorylation of constitutively nuclear STAT1. It also is possible that at least a portion of the STAT1 was tyrosine phosphorylated but below the limits of detection of our immunoblot assay.
|
The ability of IFN to stimulate both serine and tyrosine phosphorylation of STAT1, the presence of IFN in atherosclerotic lesions, and recent evidence that IFN promotes advanced plaque progression24,25 led us to explore the effect of the combination of FC loading and IFN treatment on Ser-P-STAT1 and apoptosis. FC-loaded macrophages treated with IFN showed an increase in Ser-P-STAT1 that was greater than either condition alone (Figure 3A). Note that IFN alone did not induce CHOP, nor did it further increase CHOP in the setting of FC loading. Most important, under conditions in which IFN alone induced no apoptosis, IFN treatment led to a >5-fold enhancement of FC-induced apoptosis (Figure 3B, WT). This effect of IFN required STAT1 because it was inhibited by 93% (P<0.05) in Stat1–/– macrophages (Figure 3B, Stat1–/–). Thus, in atheromata, where macrophages are likely exposed to the combination of SRA ligands, ER stressors, and IFN, the role of STAT1 in macrophage apoptosis may be particularly important (below).
|
Cytosolic Calcium, TLR4, and CaMKII Activation Is Required for Stat1 Serine Phosphorylation and Apoptosis in FC-Loaded Macrophages
Three kinases that are able to catalyze serine phosphorylation of STAT1 are p38, extracellular signal-regulated kinase (ERK), and protein kinase C-
.23 However, using a combination of gene targeting and chemical inhibitors, we found that inhibiting these kinases did not abrogate FC-induced serine phosphorylation of STAT1 (data not shown). In the face of these negative data, we next asked whether 2 critical components of the multihit model, ER stress and TLR4 signaling, were necessary for STAT1 serine phosphorylation. The data in Figure 4A and 4B show that blocking FC-induced ER stress by the cholesterol trafficking inhibitor U18666A4 or omitting thapsigargin from the fucoidan-plus-thapsigargin model markedly suppressed Ser-P-STAT1. In addition, FC-induced serine phosphorylation of STAT1 was almost completely prevented in TLR4-deficient macrophages (Figure 4C). Note that all of these manipulations also block macrophage apoptosis.4,15
|
Both ER stress and TLR4 signaling can affect cellular calcium metabolism (see Discussion).12,13,15,26,27 Moreover, we recently showed that buffering cytosolic calcium with 1,2-bis[2-aminophenoxy]ethane-N,N,N’,N’-tetraacetic acid tetrakis [acetoxymethyl ester] (BAPTA-AM) markedly inhibited both FC-induced and thapsigargin/fucoidan-induced apoptosis.15 To test the role of cytosolic calcium in STAT1 serine phosphorylation, we incubated FC-loaded macrophages with increasing concentrations of BAPTA-AM or equivalent volumes of vehicle control. As shown in Figure 5A, BAPTA-AM suppressed FC-induced serine phosphorylation of STAT1 in a dose-dependent manner.
|
One mechanism by which cytosolic calcium might participate in STAT1 serine phosphorylation is by activating CaMKII, which may directly phosphorylate STAT128 and/or lead to its phosphorylation by enhancing TLR4 signaling (see Discussion).15,29,30 As shown in Figure 5B, FC loading led to a rapid and marked enhancement of CaMKII threonine phosphorylation, which is a marker of its activation. At the 30- and 60-minute time points, the degree of activation was similar to that of the calcium ionophore A23187, a known potent activator of CaMKII. Similar results were found with fucoidan plus thapsigargin (data not shown). Note that the time course of CaMKII activation by FC loading or by thapsigargin plus fucoidan precedes the onset of STAT1 serine phosphorylation in these cells. To show a functional role for CaMKII activation in both STAT1 serine phosphorylation and apoptosis in FC-loaded macrophages, we used 2 structurally diverse CaMKII inhibitors. The data in Figure 5C and 5D show that the chemical CaMKII inhibitor KN93,31 but not the inactive homologue KN92, and the peptide CaMKII inhibitor AIP32 markedly suppressed FC-induced STAT1 serine phosphorylation. Most important, KN93 but not KN92 suppressed FC-induced apoptosis by 92% (P<0.05) (Figure 5E). Note that neither KN93 nor AIP decreased the uptake or ER trafficking of lipoprotein-derived FC or the induction of CHOP (data not shown and Figure 5D). In summary, these data indicate that cytosolic calcium and CaMKII are essential for STAT1 serine phosphorylation and apoptosis in the SRA-ER stress model. We also conducted experiments on 2 additional macrophage models, namely mouse bone marrow–derived and human peripheral blood–derived macrophages. In both of these cell types, the SRA–ER stress model exclusively induced STAT1 serine phosphorylation via a pathway mediated by cytosolic calcium and CaMKII (see the Figure in the online-only Data Supplement), suggesting the universality of this signaling pathway among macrophages.
STAT1 Is Serine Phosphorylated in Murine and Human Atherosclerotic Lesions, and STAT1 Plays a Role in Advanced Lesional Macrophage Apoptosis and Plaque Necrosis in Female Ldlr–/– Mice
To provide evidence for the relevance of Ser-P-STAT1 in atherosclerosis, we first used immunohistochemistry to assess expression of Ser-P-STAT1 in murine and human atheromata (Figures 6 and 7
). In mouse lesions, Ser-P-STAT1 was present in numerous macrophage foam cells, as assessed by staining adjacent sections with anti–Mac-3 antibody (Figure 6A and 6B) and Oil Red O (Figure 6D). As illustrated by these images, Ser-P-STAT1 staining also was observed in the endothelial cells lining the lumen, which was PECAM-1 positive (not shown), and in smooth muscle cells in the media, which were -actin positive (Figure 6F). In human lesions, staining of Ser-P-STAT1 was found in the advanced stages called pathological intimal thickening and fibroatheroma (Figure 7B and 7C) but not in the early stage of diffuse intimal thickening (Figure 7A). In the advanced lesions, most of the Ser-P-STAT1 colocalized with macrophages (Figure 7B and 7C). Note that Ser-P-STAT1 was found in the nuclei of these cells (Figure 7C, bottom middle) and in areas that were TUNEL positive, a marker of apoptosis (Figure 7C, bottom right). Of interest, some of the Ser-P-STAT1 in the most advanced fibroatheroma was found in macrophages surrounding necrotic areas (Figure 7C, top middle, asterisk).
|
|
To further investigate a causal link between STAT1 and lesional macrophage apoptosis, we compared advanced plaques of Western diet–fed Ldlr–/– mice reconstituted with either WT or Stat1–/– bone marrow. The mice were fed the Western diet for 10 or 12 weeks. Plasma lipoprotein cholesterol and body weight were similar between the 2 groups of mice (Figure 8A for 10-week protocol; data not shown for 12-week protocol). In the 10-week study, overall lesion areas were similar (Figure 8B and 8C). However, the number of TUNEL-positive cells in macrophage-rich regions was decreased by 61% (P=0.034) in the Stat1–/–
Ldlr–/– lesions, and a trend toward decreased plaque necrosis existed that did not quite reach statistical significance (P=0.078) (Figure 8C). Note that total macrophage area was not affected by STAT1 deficiency (120.0±11.8x103 and 111.5±21.3x103 µm2 in WT and Stat1–/– bone marrow recipients, respectively; P=0.72; see Discussion).
|
Plaque necrosis likely results from the eventual cellular necrosis of macrophages that become apoptotic but are not subsequently cleared by phagocytes.1,2 Therefore, we predicted that as the lesions in the 2 groups of mice progressed, the difference in necrotic core areas would become statistically significant, whereas apoptotic macrophages per se would become less numerous and less different between the 2 groups of mice. As shown by the data in Figure 8D, the necrotic cores were larger in the 12-week-diet mice, and a statistically significant difference was present in the necrotic core area (34% decrease in the Stat1–/–Ldlr–/– lesions; P=0.02) but not the number of TUNEL-positive cells. In summary, STAT1 deficiency in bone marrow–derived cells in Ldlr–/– mice has a substantial protective effect on apoptosis in the macrophage-rich lesions of advanced plaques and on plaque necrosis.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Increasing evidence from a number of laboratories suggests that an ER stress–based model of macrophage apoptosis plays an important role in advanced lesional macrophage death and plaque necrosis.4–9 The work reported here adds critical new components to this model by demonstrating essential roles for STAT1 and CaMKII in macrophage apoptosis in vitro and for STAT1 in advanced lesional macrophage apoptosis and plaque necrosis in vivo.
Further studies are required to define at a precise molecular level how the proapoptotic components elucidated in this study fit into the overall scheme of the multihit model of macrophage apoptosis. Our working hypothesis is depicted in Figure 9. We suggest that ER stress triggers 2 key proapoptotic processes: UPR/CHOP and another pathway in which ER stress–induced cytosolic calcium activates CaMKII, which in turn leads to serine phosphorylation of proapoptotic STAT1. Activation of the TLR4-MyD88 pathway by SRA ligands, which is critical for apoptosis,15 also contributes to STAT1 serine phosphorylation. SRA ligands additionally promote apoptosis through SRA-dependent suppression of prosurvival IFNβ.14,15
|
This scheme raises a number of critical issues that require further investigation. Among these is whether STAT1 serine phosphorylation per se is required for apoptosis, which is consistent with our data and with previous work showing a proapoptotic role of Ser-P-STAT1 in apoptosis in other systems.33 However, definitive proof requires comparing SRA/ER stress–induced apoptosis in macrophages containing S727- with Y701-mutated STAT1.22,33 Until then, we cannot definitively rule out the possibility that apoptosis requires Y701 phosphorylation and that Tyr-P-STAT1 in our SRA–ER stress model is below the limit of immunoblot detection. In pilot studies, we found that apoptosis induced by thapsigargin and fucoidan was markedly suppressed in peritoneal macrophages from S727A-STAT1 knock-in mice, but results with FC-induced apoptosis were difficult to interpret because of an as-yet-undefined compensatory pathway (J.M.T., W.L., T. Decker, PhD, and I.T., unpublished data, 2007). Assuming that Ser-P-STAT1 is a key apoptosis mediator in this pathway, the next goal is to elucidate whether and how serine-only phosphorylated STAT1 affects gene transcription in a manner that promotes apoptosis.33–35 A related issue is the precise mechanism by which STAT1 is serine phosphorylated and how this process is linked to both CaMKII and TLR4 (Figure 9). One obvious possibility is that CaMKII directly phosphorylates STAT1, as has been described previously in other models.28 If this is the case in our model, a link to TLR4 could occur through IP3 receptor–mediated elevation of cytosolic calcium,26 leading to a further increase in CaMKII activation. Alternatively, TLR4 signaling may stimulate STAT1 serine phosphorylation more directly, as has been reported in other models using the TLR4 ligand lipopolysaccharide.29,30
The impetus for this study was to explore pathways that may be involved in promoting macrophage apoptosis in atherosclerosis. The ultimate significance of lesional macrophage apoptosis likely depends on lesion stage.1,2 In early lesions, rapid and efficient phagocytic clearance of apoptotic macrophages appears to limit lesion cellularity and progression. Of interest, STAT1 may have a separate role in these early lesions that is independent of macrophage death because STAT1 deficiency in Apoe–/– mice blocks foam cell formation and early lesion development.36 In advanced lesions, however, evidence exists that clearance of apoptotic cells is defective, leading to postapoptotic macrophage necrosis, inflammation, and eventually overall plaque necrosis.1,2 In this context, the multihit model of macrophage apoptosis is likely most relevant to advanced lesions. For example, immunoblots have shown that CHOP is expressed only in advanced lesions7 and that manipulation of ER stress in vivo is positively associated with advanced lesional necrosis, not negatively associated with early lesion progression.5,37 In the case of STAT1 deficiency, a clear trend toward decreased plaque necrosis was present. However, the maximum effect on plaque necrosis may lag behind that of macrophage apoptosis because plaque necrosis likely results from the progressive coalescence of apoptotic macrophages after they become secondarily necrotic.1,2 Another prediction from this idea and from the fact that the anti-macrophage antibody used in our study recognizes prenecrotic apoptotic macrophages is that total macrophage area should be similar in Stat1+/+Ldlr–/– and Stat1–/–Ldlr–/– lesions, exactly as we observed experimentally. More fundamentally, we clearly did not observe an increase in lesion area in the Stat1–/– group, which is what is found when early lesional macrophage apoptosis is blocked.38 In terms of other studies linking STAT1 to advanced plaque progression, in vivo data suggest that interleukin-10, which suppresses STAT1 activity,39 may protect advanced atheromata from macrophage apoptosis and plaque necrosis.40,41 Moreover, Koga et al25 reported that blocking the function of the STAT1 activator IFN stabilized advanced plaques in Apoe–/– mice. Thus, pending further in vivo studies, local inhibition of STAT1 activity may represent a potentially promising therapeutic strategy to prevent the progression of relatively benign lesions to those with increased macrophage apoptosis and plaque necrosis.
|
Acknowledgments |
|---|
We thank Dr Chris Schindler for helpful discussions and for supplying the Stat1–/– mice, Dr Mary Reyland for providing the Pkcd–/– mice, and George Kuriakose for assistance with the mouse atherosclerosis experiment.
Sources of Funding
This work was supported by an American Heart Association–Heritage Affiliate Post-Doctoral Fellowship (to Dr Lim), a T32 training grant from the National Institutes of Health (HL007343 to Dr Timmins), an individual postdoctoral training grant from the National Institutes of Health (HL79801 to Dr Seimon), and National Institutes of Health grants HL54591, HL87123, and HL75662 and US Army Medical Research and Materiel Command grant W81XWH-06-1-0212 (to Dr Tabas).
Disclosures
None.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol. 2005; 25: 2255–2264.
2. Schrijvers DM, De Meyer GR, Herman AG, Martinet W. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res. 2007; 73: 470–480.
3. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002; 15: 439–446.[Medline] [Order article via Infotrieve]
4. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol. 2003; 5: 781–792.[CrossRef][Medline] [Order article via Infotrieve]
5. Feng B, Zhang D, Kuriakose G, Devlin CM, Kockx M, Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci U S A. 2003; 100: 10423–10428.
6. Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, Austin RC. TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia. J Biol Chem. 2003; 278: 30317–30327.
7. Zhou J, Lhotak S, Hilditch BA, Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E–deficient mice. Circulation. 2005; 111: 1814–1821.
8. Gargalovic PS, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Baruch-Oren T, Berliner JA, Kirchgessner TG, Lusis AJ. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol. 2006; 26: 2490–2496.
9. Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, Hatakeyama K, Asada Y, Okada K, Ishibashi-Ueda H, Gabbiani G, Bochaton-Piallat ML, Mochizuki N, Kitakaze M. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation. 2007; 116: 1226–1233.
10. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004; 18: 3066–3077.
11. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest. 2002; 110: 905–911.[CrossRef][Medline] [Order article via Infotrieve]
12. Li Y, Ge M, Ciani L, Kuriakose G, Westover E, Dura M, Covey D, Freed JH, Maxfield FR, Lytton J, Tabas I. Enrichment of endoplasmic reticulum with cholesterol inhibits SERCA2b activity in parallel with increased order of membrane lipids: implications for depletion of ER calcium stores and apoptosis in cholesterol-loaded macrophages. J Biol Chem. 2004; 279: 37030–37039.
13. Chen LY, Chiang AS, Hung JJ, Hung HI, Lai YK. Thapsigargin-induced grp78 expression is mediated by the increase of cytosolic free calcium in 9L rat brain tumor cells. J Cell Biochem. 2000; 78: 404–416.[CrossRef][Medline] [Order article via Infotrieve]
14. DeVries-Seimon T, Li Y, Yao PM, Stone E, Wang Y, Davis RJ, Flavell R, Tabas I. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J Cell Biol. 2005; 171: 61–73.
15. Seimon TA, Obstfeld A, Moore KJ, Golenbock DT, Tabas I. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A. 2006; 103: 19794– 19799.
16. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994; 63: 601–637.[Medline] [Order article via Infotrieve]
17. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol. 1997; 8: 275–280.[Medline] [Order article via Infotrieve]
18. Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol. 2004; 173: 1166–1170.
19. Kockx MM. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol. 1998; 18: 1519–1522.
20. Wong AH, Tam NW, Yang YL, Cuddihy AR, Li S, Kirchhoff S, Hauser H, Decker T, Koromilas AE. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 1997; 16: 1291–1304.[CrossRef][Medline] [Order article via Infotrieve]
21. Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000; 19: 2468–2473.[CrossRef][Medline] [Order article via Infotrieve]
22. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, Muller M, Decker T. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity. 2003; 19: 793–802.[CrossRef][Medline] [Order article via Infotrieve]
23. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000; 19: 2628–2637.[CrossRef][Medline] [Order article via Infotrieve]
24. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999; 145: 33–43.[CrossRef][Medline] [Order article via Infotrieve]
25. Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, Imaizumi T. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res. 2007; 101: 344–356.
26. Prpic V, Weiel JE, Somers SD, DiGuiseppi J, Gonias SL, Pizzo SV, Hamilton TA, Herman B, Adams DO. Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5-bisphosphate in murine peritoneal macrophages. J Immunol. 1987; 139: 526–533.[Abstract]
27. Cuschieri J, Bulger E, Garcia I, Jelacic S, Maier RV. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. Shock. 2005; 23: 99–106.[CrossRef][Medline] [Order article via Infotrieve]
28. Nair JS, DaFonseca CJ, Tjernberg A, Sun W, Darnell JE Jr, Chait BT, Zhang JJ. Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. Proc Natl Acad Sci U S A. 2002; 99: 5971–5976.
29. Rhee SH, Jones BW, Toshchakov V, Vogel SN, Fenton MJ. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J Biol Chem. 2003; 278: 22506–22512.
30. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol. 2002; 3: 392–398.[CrossRef][Medline] [Order article via Infotrieve]
31. Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, Hidaka H. The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun. 1991; 181: 968–975.[CrossRef][Medline] [Order article via Infotrieve]
32. Ishida A, Shigeri Y, Tatsu Y, Uegaki K, Kameshita I, Okuno S, Kitani T, Yumoto N, Fujisawa H. Critical amino acid residues of AIP, a highly specific inhibitory peptide of calmodulin-dependent protein kinase II. FEBS Lett. 1998; 427: 115–118.[CrossRef][Medline] [Order article via Infotrieve]
33. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science. 1997; 278: 1630–1632.
34. Stephanou A, Scarabelli TM, Brar BK, Nakanishi Y, Matsumura M, Knight RA, Latchman DS. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem. 2001; 276: 28340–28347.
35. Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R, Darnell JE Jr. Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. EMBO J. 1998; 17: 6963–6971.[CrossRef][Medline] [Order article via Infotrieve]
36. Agrawal S, Febbraio M, Podrez E, Cathcart MK, Stark GR, Chisolm GM. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Circulation. 2007; 115: 2939–2947.
37. Han S, Liang CP, DeVries-Seimon T, Ranalletta M, Welch CL, Collins-Fletcher K, Accili D, Tabas I, Tall AR. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 2006; 3: 257–266.[CrossRef][Medline] [Order article via Infotrieve]
38. Liu J, Thewke DP, Su YR, Linton MF, Fazio S, Sinensky MS. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol. 2005; 25: 174–179.
39. Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly RP, Larner AC, Finbloom DS. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood. 1999; 93: 1456–1463.
40. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol. 1999; 19: 611–616.
41. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res. 2002; 90: 1064–1071.
|
Footnotes |
|---|
The online-only Data Supplement, consisting of Methods and a figure, can be found with this article at http://circ.ahajournals.org/cgi/content/full/ CIRCULATIONAHA.107.711275/DC1.
Related Article:
Circulation 2008 117: 857-859.
This article has been cited by other articles:
 |
|
 |
|
  K. E. Barnholt, R. S. Kota, H. H. Aung, and J. C. Rutledge Adenosine Blocks IFN-{gamma}-Induced Phosphorylation of STAT1 on Serine 727 to Reduce Macrophage Activation J. Immunol., November 15, 2009; 183(10): 6767 - 6777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, M. Mongillo, K.-T. Chin, H. Harding, D. Ron, A. R. Marks, and I. Tabas Role of ERO1-{alpha}-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis J. Cell Biol., September 21, 2009; 186(6): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ortiz-Munoz, J. L. Martin-Ventura, P. Hernandez-Vargas, B. Mallavia, V. Lopez-Parra, O. Lopez-Franco, B. Munoz-Garcia, P. Fernandez-Vizarra, L. Ortega, J. Egido, et al. Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Seimon and I. Tabas Mechanisms and consequences of macrophage apoptosis in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S382 - S387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Thorp, Y. Li, L. Bao, P. M. Yao, G. Kuriakose, J. Rong, E. A. Fisher, and I. Tabas Brief Report: Increased Apoptosis in Advanced Atherosclerotic Lesions of Apoe-/- Mice Lacking Macrophage Bcl-2 Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 169 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Thorp, D. Cui, D. M. Schrijvers, G. Kuriakose, and I. Tabas Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe-/- Mice Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1421 - 1428. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||